Medtronic Reports Early FDA Approval for CorValve System, Cites Exceptional Clinical Performance

Medtronic, Inc. (NYSE: MDT ) today announced the U.S. Food and Drug Administration (FDA) approval of the self-expanding transcatheter CoreValve^® System for severe aortic stenosis patients who are too ill or frail to have their aortic valves replaced through traditional open-heart surgery. Untreated, these patients have a risk of dying approaching 50 percent at